acebutolol has been researched along with atenolol in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (43.02) | 18.7374 |
1990's | 19 (22.09) | 18.2507 |
2000's | 16 (18.60) | 29.6817 |
2010's | 11 (12.79) | 24.3611 |
2020's | 3 (3.49) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Baker, JG | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bernheim, J; Labeeuw, M; Pellet, M; Pozet, N; Sassard, J; Traeger, J; Zech, P | 1 |
Gooren, L; Harms, HH; Hesse, C; Spoelstra, AJ; Verschoor, L | 1 |
Wilcox, RG | 1 |
Kiechel, JR; Meier, J | 1 |
Aubert, P; Chaignon, M; Guédon, J; Lucsko, M | 1 |
Hugues, FC; Julien, D; Marche, J | 1 |
Barnett, D; Deacon, SP; Karunanayake, A | 1 |
Cherchi, A; Sau, F; Seguro, C | 1 |
Leloux, MS; Niessen, WM; van der Hoeven, RA | 1 |
Abiteboul, M; Chenard, A; De Kermadec, JM; Tertrain, F; Weiss, Y | 1 |
Behr, U; Franz, IW; Ketelhut, R; Tönnesmann, U | 2 |
Cheung, DG; Graettinger, WF; Neutel, JM; Schnaper, H; Weber, MA | 1 |
Pala, AM; Ricciardelli, D; Sanna, A; Vinattieri, MA | 1 |
Carlsen, JE; McNair, A; Svendsen, TL; Trap-Jensen, J | 1 |
Jackson, PR; Lewis, RV; Ramsay, LE | 1 |
de Boo, T; Lemmens, WA; Lenders, JW; Salemans, J; Thien, T; van't Laar, A | 1 |
Fishbein, L; Jackson, CD | 1 |
Barberis, S; Galietti, F; Giorgis, GE; Massaglia, GM; Miravalle, C; Onoscuri, E | 1 |
Jones, DM; Kilminster, SG; Lewis, MJ | 1 |
Lavanchy, N; Martin, J; Rossi, A | 1 |
Keller, N; Larsen, J; Storm, T; Sykulski, R; Thamsborg, G | 1 |
Amano, M; Fujii, J; Imataka, K; Ishibashi, M; Kitahara, Y; Nakaoka, H; Yamaji, T | 1 |
Boomsma, F; Man in 't Veld, AJ; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ | 1 |
De Backer, G | 1 |
Brocklehurst, JC; Napier, RN; Turner, AS | 1 |
Hedges, A; Kilfeather, S; Lima, DR; Turner, P | 1 |
Greefhorst, AP; van Herwaarden, CL | 1 |
Dalal, JJ; Dart, AM; Griffith, TM; Henderson, AH; Penny, WJ | 1 |
Henderson, A; Lewis, M; Ross, J; Sheridan, D | 1 |
Behrenbeck, DW; Braun, V; Gil-Sanchez, D; Hilger, HH; Hombach, V; Höpp, HW; Tauchert, M | 1 |
Catherine, P; Dubois, D; Klepper, A; Petitcolas, J; Temperville, B | 1 |
Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y | 1 |
Bralet, J; Didier, JP; Moreau, D; Opie, LH; Rochette, L | 1 |
Amlie, JP; Landmark, K; Refsum, H | 1 |
Baldwin, CJ; Gribbin, HR; Mackay, AD; Tattersfield, AE | 1 |
Costa, AG; da Costa, PS; de Moraes, LB | 1 |
Brocklehurst, JC; Turner, AS | 1 |
Dart, AM; Henderson, AH; Jones, DM; Lewis, MJ | 1 |
Jewitt, DE | 1 |
Boissier, JR; Giudicelli, JF; Richer, C; Venturini-Souto, N | 1 |
Gobburu, JV; Shelver, WH | 1 |
Klug, S; Merker, HJ; Neubert, D; Schwabe, R; Thiel, R | 1 |
Chanard, J; Durand, D; el Esper, N; Fournier, A; Godin, M; Goldfarb, B; Hannedouche, T; Landais, P; Mignon, F; Suo, JM | 1 |
Iisalo, E; Kaila, T | 1 |
Dyer, RB; Mitha, AS; Patel, JJ | 1 |
Crichton, F | 1 |
Murakami, H; Nishimura, M; Urabe, K | 1 |
Arnhold, J; Arnold, K; Seifert, T; Zschörnig, O | 1 |
Gemba, M; Hosaka, K; Kamiyama, M; Kobayashi, I; Konno, C; Maruo, H; Ueno, T | 1 |
Mahmood, I | 1 |
Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
Black, M; Cayenne, S; Cohen, TJ; Doolittle, S; Ibrahim, B; Quan, W | 1 |
Krzek, J; Kwiecień, A; Zylewski, M | 1 |
Abrahamowicz, M; Austin, PC; Eisenberg, MJ; Humphries, K; Pilote, L; Richard, H; Rinfret, S; Tu, J | 1 |
Alekseeva, IuM; Malkina, TA; Sokolov, SF | 1 |
Pisklak, DM; Wawer, I; Zielińska-Pisklak, MA | 1 |
Armaković, S; Armaković, SJ; Setrajčić, IJ; Setrajčić, JP | 1 |
Khalit, WN; Tay, KS | 1 |
Brockmöller, J; Jensen, O; Rafehi, M; Tzvetkov, MV | 1 |
Ansorge, M; Dovhunová, M; Galić, N; Habinovec, I; Pocrnić, M; Tesařová, E | 1 |
Carlo, MJ; Patrick, AL | 1 |
5 review(s) available for acebutolol and atenolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Hemodynamic effects of newer antiarrhythmic drugs.
Topics: Acebutolol; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Atenolol; Benzeneacetamides; Disopyramide; Dogs; Hemodynamics; Humans; Mexiletine; Piperidines; Tocainide; Verapamil | 1980 |
20 trial(s) available for acebutolol and atenolol
Article | Year |
---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.
Topics: Acebutolol; Adolescent; Adult; Atenolol; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diet, Diabetic; Double-Blind Method; Female; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Propanolamines; Propranolol | 1977 |
Maintenance of blood pressure control in elderly hypertensives on ketoprofen.
Topics: Acebutolol; Aged; Aged, 80 and over; Aging; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Heart Rate; Humans; Hypertension; Incidence; Ketoprofen; Male | 1991 |
[Regression of left ventricular hypertrophy in hypertensive patients under long-term therapy with antihypertensive agents].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Female; Gallopamil; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nifedipine; Time Factors | 1990 |
Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements.
Topics: Acebutolol; Adult; Aged; Atenolol; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged | 1990 |
[Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Cardiac Volume; Cardiomegaly; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Gallopamil; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged; Nifedipine | 1989 |
[The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrocardiography; Female; Humans; Hypertension; Middle Aged; Penbutolol; Randomized Controlled Trials as Topic; Regression Analysis | 1989 |
The influence of intrinsic sympathomimetic activity and beta-1 receptor selectivity on the recovery of finger skin temperature after finger cooling in normotensive subjects.
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Drug Evaluation; Female; Fingers; Forearm; Heart Rate; Humans; Male; Pindolol; Propranolol; Random Allocation; Skin Temperature | 1986 |
Anxiolytic effects of acebutolol and atenolol in healthy volunteers with induced anxiety.
Topics: Acebutolol; Adult; Anti-Anxiety Agents; Anxiety; Atenolol; Humans; Male; Psychomotor Performance | 1988 |
Atrial natriuretic peptide during exercise in patients with coronary heart disease before and after single dose atenolol and acebutolol.
Topics: Acebutolol; Aged; Atenolol; Atrial Natriuretic Factor; Clinical Trials as Topic; Coronary Disease; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation | 1988 |
Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension.
Topics: Acebutolol; Adult; Aged; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation; Triglycerides | 1988 |
Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison.
Topics: Acebutolol; Adult; Aged; Atenolol; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1985 |
Comparative study of the ventilatory effects of three beta 1-selective blocking agents in asthmatic patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Bronchi; Clinical Trials as Topic; Heart Rate; Humans; Male; Metoprolol; Pulmonary Ventilation; Respiration; Terbutaline; Vital Capacity | 1981 |
[Comparison of the anti-hypertensive effects of combinations of nifedipine retard with acebutolol or atenolol].
Topics: Acebutolol; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine | 1984 |
Comparison of efficacy of a single daily dose of 400 mg acebutolol and 100 mg atenolol in the treatment of arterial hypertension.
Topics: Acebutolol; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Pulse; Time Factors | 1983 |
The psychological side effects of acebutolol and atenolol.
Topics: Acebutolol; Adult; Aged; Anxiety; Arousal; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged | 1984 |
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.
Topics: Acebutolol; Adolescent; Adult; Aged; Atenolol; Blood Pressure; Body Weight; Enalapril; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Proteinuria | 1994 |
Selectivity of acebutolol, atenolol, and metoprolol in healthy volunteers estimated by the extent the drugs occupy beta 2-receptors in the circulating plasma.
Topics: Acebutolol; Administration, Oral; Adult; Animals; Atenolol; Double-Blind Method; Humans; Male; Metoprolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Time Factors | 1993 |
Beta adrenergic blockade does not improve effort tolerance in patients with mitral stenosis in sinus rhythm.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Cross-Over Studies; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Mitral Valve Stenosis; Oxygen Consumption; Ventilation-Perfusion Ratio | 1995 |
[Interrelationship between changes of rate and variability of cardiac rhythm under influence of beta-adrenoblockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Treatment Outcome | 2007 |
61 other study(ies) available for acebutolol and atenolol
Article | Year |
---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Acute renal effects of new beta-adrenergic receptor site blocking agents on renal function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aminohippuric Acids; Atenolol; Chlorides; Glomerular Filtration Rate; Humans; Hypertension; Inulin; Kidney; Sodium | 1976 |
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Fatty Acids, Nonesterified; Heart Rate; Humans; Insulin; Isoproterenol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Renin | 1978 |
[beta-blockers in hypertension with renal failure].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Propranolol; Renal Dialysis; Renin; Sodium; Vasodilator Agents | 1978 |
[Effects of beta blockaders on ventilatory function in chronic bronchitis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bronchitis; Chronic Disease; Coronary Disease; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Practolol; Propranolol; Respiration; Vital Capacity | 1979 |
[Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Pindolol; Timolol; Ventricular Function | 1991 |
Thermospray liquid chromatography/mass spectrometry of polar beta-blocking drugs: preliminary results.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Labetalol; Sotalol | 1991 |
Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Output; Coronary Disease; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Practolol; Propranolol | 1985 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1985 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Metaproterenol; Middle Aged; Pindolol; Propranolol | 1986 |
Comparative study of the effects of acebutolol, atenolol, d-propranolol and dl,-propranolol on the alterations in energy metabolism caused by ischemia and reperfusion: a 31P NMR study on the isolated rat heart.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Disease; Energy Metabolism; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Reperfusion; Myocardium; Propranolol; Rats | 1988 |
Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
Topics: Acebutolol; Adult; Aged; Aldosterone; Atenolol; Atrial Natriuretic Factor; Cyclic GMP; Female; Humans; Hypertension; Male; Middle Aged; Renin | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolol; Propranolol; Renin; Time Factors; Vasodilation | 1988 |
Comparison of four different beta-adrenoceptor blocking drugs on lymphocyte isoprenaline-stimulated cyclic AMP production.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Cyclic AMP; Drug Interactions; Female; Humans; Isoproterenol; Lymphocytes; Male; Middle Aged; Pindolol; Timolol | 1981 |
Perverse T waves and chronic beta-blocker treatment.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Electrocardiography; Humans; Male; Middle Aged; Propranolol | 1982 |
Factors relating to the beta blocker withdrawal syndrome.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Rate; Humans; Hyperthyroidism; Oxprenolol; Propranolol; Substance Withdrawal Syndrome; Valsalva Maneuver | 1981 |
Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrophysiology; Female; Heart; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Rest; Sympathomimetics | 1982 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; Birth Weight; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Resuscitation | 1982 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1983 |
Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Cardiac Output; Coronary Circulation; Male; Myocardium; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Tritium | 1984 |
Classification of cardioactive drugs in vivo by using programmed electrical stimulation in combination with monophasic action potential recordings at different pacing rates.
Topics: Acebutolol; Acecainide; Action Potentials; Animals; Anti-Arrhythmia Agents; Atenolol; Butyrophenones; Cardiac Pacing, Artificial; Computers; Dogs; Female; Heart Rate; Male; Myocardial Contraction; Nifedipine | 1981 |
Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.
Topics: Acebutolol; Airway Resistance; Atenolol; Bronchi; Dose-Response Relationship, Drug; Ethanolamines; Heart; Heart Rate; Humans; Labetalol; Physical Exertion; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Topics: Acebutolol; Animals; Atenolol; Blood Pressure; Body Weight; Depression, Chemical; Hemodynamics; Hypertension; Male; Propanolamines; Propranolol; Rats; Renin | 1980 |
Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Models, Statistical; Neural Networks, Computer; Pharmacokinetics; Structure-Activity Relationship | 1995 |
Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; In Vitro Techniques; Metoprolol; Pindolol; Propranolol; Rats; Rats, Wistar | 1994 |
Beta blockers in pregnancy and their effect on regional Doppler ultrasound and fetal weight.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Body Weight; Female; Fetus; Humans; Placental Circulation; Pregnancy; Ultrasonography, Doppler; Ultrasonography, Prenatal | 1996 |
Relation between dynamic midventricular obstruction and unexplained chest pain in patients with normal echocardiograms at rest.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Atenolol; Dobutamine; Echocardiography, Doppler, Color; Female; Humans; Male; Metoprolol; Middle Aged; Rest; Ventricular Outflow Obstruction | 1996 |
Beta-blockers inhibit the modification of low-density lipoproteins by sodium hypochlorite in vitro.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Atenolol; Bepridil; Biphenyl Compounds; Chemical Phenomena; Chemistry; Cholesterol Esters; Diclofenac; Free Radicals; Humans; Lipoproteins, LDL; Macrophages; Molecular Structure; Oxprenolol; Particle Size; Picrates; Sodium Hypochlorite; Spectrum Analysis; Thiobarbituric Acid Reactive Substances | 1997 |
Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin.
Topics: Acebutolol; Administration, Cutaneous; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dermatitis, Irritant; Guinea Pigs; Male; Oxprenolol; Skin; Skin Absorption; Timolol | 1997 |
Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Amiloride; Anti-Arrhythmia Agents; Anti-Infective Agents; Area Under Curve; Atenolol; Biological Availability; Diuretics; Enoxacin; Flecainide; Histamine H2 Antagonists; Humans; Imidazoles; Kidney; Middle Aged; Ranitidine; Renal Insufficiency; Tiopronin | 1997 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Retrospective Studies; Sympathomimetics; Syncope, Vasovagal; Tilt-Table Test | 1999 |
Stability of atenolol, acebutolol and propranolol in acidic environment depending on its diversified polarity.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Drug Stability; Hydrochloric Acid; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Propranolol; Static Electricity; Temperature; Thermodynamics | 2006 |
A population-based analysis of the class effect of beta-blockers after myocardial infarction.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Male; Metoprolol; Myocardial Infarction | 2007 |
1H and 13C NMR characteristics of β-blockers.
Topics: Acebutolol; Acids; Adrenergic beta-Antagonists; Alkalies; Alprenolol; Atenolol; Carbazoles; Carbon Isotopes; Carvedilol; Nuclear Magnetic Resonance, Biomolecular; Pindolol; Propanolamines; Propranolol; Protons; Timolol | 2011 |
Active components of frequently used β-blockers from the aspect of computational study.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Computer Simulation; Hardness; Humans; Hydrocarbons, Aromatic; Magnetic Resonance Spectroscopy; Metoprolol; Models, Molecular; Molecular Conformation; Static Electricity | 2012 |
Aqueous chlorination of acebutolol: kinetics, transformation by-products, and mechanism.
Topics: Acebutolol; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Chlorine; Chromatography, Liquid; Halogenation; Kinetics; Mass Spectrometry; Oxidation-Reduction; Propranolol; Water; Water Pollutants, Chemical; Water Purification | 2016 |
Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.
Topics: Acebutolol; Adrenergic Agonists; Adrenergic Antagonists; Atenolol; Biological Transport; Fenoterol; Formoterol Fumarate; HEK293 Cells; Humans; Kinetics; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Stereoisomerism | 2020 |
Chiral separation of beta-blockers by high-performance liquid chromatography and determination of bisoprolol enantiomers in surface waters.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Labetalol; Metoprolol; Water | 2020 |
Further exploration of the collision-induced dissociation of select beta blockers: Acebutolol, atenolol, bisoprolol, carteolol, and labetalol.
Topics: Acebutolol; Atenolol; Bisoprolol; Carteolol; Chromatography, Liquid; Labetalol; Tandem Mass Spectrometry | 2023 |